Table 2. Patient-related characteristics, patient distribution according to treatment strategy, and evaluation of treatment outcomes including conventional probing measurements and the COM.
| Characteristics | Values | ||
|---|---|---|---|
| Age | 42.6±12.48 | ||
| Sex | |||
| Male | 12 (60) | ||
| Female | 8 (40) | ||
| Treatment strategies | |||
| SFA | 20 sites (50) | ||
| DFA | 20 sites (50) | ||
| SFA (conventional) at 6 months | |||
| CAL change (mm) | 1.61±0.18 (0–3) | ||
| Six-month pocket depth (mm) | 3.13±0.53 (2–4) | ||
| SFA (COM) (20 sites) at 6 months | |||
| CAL gain ≥1 mm | |||
| Residual pocket depth ≤3 mm | 8 sites (40) | ||
| Residual pocket depth >3 mm | 8 sites (40) | ||
| CAL gain <1 mm | |||
| Residual pocket depth ≤3 mm | 2 sites (10) | ||
| Residual pocket depth >3 mm | 2 sites (10) | ||
| DFA (conventional) at 6 months | |||
| CAL change (mm) | 1.12±0.52 (0–3) | ||
| Six-month pocket depth (mm) | 3.43±0.57 (2–4) | ||
| DFA (COM) (20 sites) at 6 months | |||
| CAL gain ≥1 mm | |||
| Residual pocket depth ≤3 mm | 2 sites (10) | ||
| Residual pocket depth >3 mm | 9 sites (45) | ||
| CAL gain <1 mm | |||
| Residual pocket depth ≤3 mm | 2 sites (10) | ||
| Residual pocket depth >3 mm | 7 sites (35) | ||
| SFA (20 sites) at 6 months | |||
| Recession <1 mm | 18 (90) | ||
| Recession >1 mm | 2 (10) | ||
| DFA (20 sites) at 6 months | |||
| Recession <1 mm | 11 (55) | ||
| Recession >1 mm | 9 (45) | ||
Values are presented as number (%) or mean±standard deviation (range). Data are shown as follow: CAL gain ≥1 mm, recession <1 mm: treatment successful; CAL gain <1 mm, recession >1 mm: treatment failure; residual pocket depth, no significance in COM.
COM: composite outcome measure, SFA: single-flap approach, DFA: double-flap approach, CAL: clinical attachment level, SD: standard deviation.